Antibiotic modulation of the plasminogen binding ability of viridans group streptococci

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 458-463

  Teles, Cristina ^a   Smith, Andrew ^b   Lang, Sue ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LINEZOLID; PENICILLIN G; PLASMINOGEN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUINIS; UPREGULATION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; ENDOCARDITIS, BACTERIAL; FIBRINOLYSIN; GENE EXPRESSION REGULATION, BACTERIAL; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; PENICILLINS; PHOSPHOPYRUVATE HYDRATASE; PLASMINOGEN; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUIS; VANCOMYCIN;

EID: 84455170153     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00452-11     Document Type: Article

References (34)

1. Ahmed NA, Petersen FC, Scheie AA. 2009. AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics. Antimicrob. Agents Chemother. 53:4258-4263.
2. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl. 1):5-16.
3. Antikainen J, Kuparinen V, Lähteenmaki K, Korhonen TK. 2007. Enolases from Gram-positive bacterial pathogens and commensal lactobacilli share functional similarity in virulence-associated traits. FEMS Immunol. Med. Microbiol. 51:526-534. (Pubitemid 350076163)
4. Attali C, Durmort C, Vernet T, Di Guilmi AM. 2008. The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect. Immun. 76:5350-5356.
5. Bashore TM, Cabell C, Fowler V, Jr. 2006. Update on infective endocarditis. Curr. Probl. Cardiol. 31:274-352.
6. Cvitkovitch DG, Li YH, Ellen RP. 2003. Quorum sensing and biofilm formation in streptococcal infections. J. Clin. Invest. 112:1626-1632. (Pubitemid 38063718)
7. Di Salvo G, et al. 2001. Echocardiography predicts embolic events in infective endocarditis. J. Am. Coll. Cardiol. 37:1069-1076. (Pubitemid 32217608)
8. Fischetti VA, Novick R, Ferretti J, Portnoy D, Rood J (ed). 2000. Gram-positive pathogens. ASM Press, Washington, DC.
9. Ge J, Catt DM, Gregory RL. 2004. Streptococcus mutans surface alpha-enolase binds salivary mucin MG2 and human plasminogen. Infect. Immun. 72:6748-6752. (Pubitemid 39425466)
10. Goh EB, et al. 2002. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl. Acad. Sci. U. S. A. 99:17025-17030.
11. Jones MN, Holt RG. 2004. Activation of plasminogen by Streptococcus mutans. Biochem. Biophys. Res. Commun. 322:37-41. (Pubitemid 39093838)
12. Jones MN, Holt RG. 2007. Cloning and characterization of an alpha-enolase of the oral pathogen Streptococcus mutans that binds human plasminogen. Biochem. Biophys. Res. Commun. 364:924-929. (Pubitemid 350087889)
13. Jun DH, et al. 2009. Pulmonary emboli originating from infective endocarditis of the mitral valve migrating through an atrial septal defect. Int. J. Cardiol. 133:e3-e5.
14. Khil J, et al. 2003. Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms. J. Infect. Dis. 188:497-505. (Pubitemid 37011800)
15. Kinnby B, Booth NA, Svensater G. 2008. Plasminogen binding by oral streptococci from dental plaque and inflammatory lesions. Microbiology 154:924-931. (Pubitemid 351736306)
16. Lähteenmaki K, Kuusela P, Korhonen TK. 2001. Bacterial plasminogen activators and receptors. FEMS Microbiol. Rev. 25:531-552. (Pubitemid 34019193)
17. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. (Pubitemid 34164012)
18. McCaughan JA, Purvis JA, Sharkey RA. 2009. Embolisation of vegetation to the liver in right sided infective endocarditis. Eur. J. Intern. Med. 20:e32-e33.
19. Mesak LR, Miao V, Davies J. 2008. Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus. Antimicrob. Agents Chemother. 52:3394-3397.
20. Murdoch DR, et al. 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 169:463-473.
21. Nelson D, et al. 2001. pH-regulated secretion of a glyceraldehyde-3- phosphate dehydrogenase from Streptococcus gordonii FSS2: purification, characterization, and cloning of the gene encoding this enzyme. J. Dent. Res. 80:371-377. (Pubitemid 32501340)
22. Parry MA, Zhang XC, Bode I. 2000. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. Trends Biochem. Sci. 25:53-59. (Pubitemid 30100366)
23. Pecharki D, Petersen FC, Scheie AA. 2008. LuxS and expression of virulence factors in Streptococcus intermedius. Oral Microbiol. Immunol. 23:79-83. (Pubitemid 350308570)
24. Rogers PD, et al. 2007. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J. Antimicrob. Chemother. 59:616-626. (Pubitemid 47073393)
25. Smith K, et al. 2010. Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54:380-387.
26. Steckelberg JM, et al. 1991. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann. Intern. Med. 114:635-640.
27. Stinson MW, Alder S, Kumar S. 2003. Invasion and killing of human endothelial cells by viridans group streptococci. Infect. Immun. 71:2365-2372. (Pubitemid 36519847)
28. Svensson MD, Sjobring U, Luo F, Bessen DE. 2002. Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology 148:3933-3945. (Pubitemid 36097455)
29. Taylor MB, Oh JH, Kang KL, Chow VT. 2005. Intermedilysin release by Streptococcus intermedius: effects of various antibacterial drugs at sub-MIC levels. FEMS Microbiol. Lett. 243:379-384. (Pubitemid 40431203)
30. Teles C, Smith A, Ramage G, Lang S. 2011. Identification of clinically relevant viridans group streptococci by phenotypic and genotypic analysis. Eur. J. Clin. Microbiol. Infect. Dis. 30:243-250.
31. Teles C, Smith A, Ramage G, Lang S. 2011. The role of streptococcal plasmin(ogen) binding in infective endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 30:127-129.
32. Vilacosta I, et al. 2002. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J. Am. Coll. Cardiol. 39:1489-1495. (Pubitemid 34439065)
33. Walker MJ, McArthur JD, McKay F, Ranson M. 2005. Is plasminogen deployed as a Streptococcus pyogenes virulence factor? Trends Microbiol. 13:308-313. (Pubitemid 40884465)
34. Yim G, Wang HH, Davies J. 2006. The truth about antibiotics. Int. J. Med. Microbiol. 296:163-170. (Pubitemid 43375999)